Cargando…
Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity
Tubulin has been regarded as an attractive and successful molecular target in cancer therapy and drug discovery. Vicinal diaryl is a simple scaffold found in many colchicine site tubulin inhibitors, which is also an important pharmacophoric point of tubulin binding and anti-cancer activity. As the c...
Autores principales: | Liu, Xu, Pang, Xiao-Jing, Liu, Yuan, Liu, Wen-Bo, Li, Yin-Ru, Yu, Guang-Xi, Zhang, Yan-Bing, Song, Jian, Zhang, Sai-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272053/ https://www.ncbi.nlm.nih.gov/pubmed/34279387 http://dx.doi.org/10.3390/molecules26134047 |
Ejemplares similares
-
Discovery of novel diarylamides as orally active diuretics targeting urea transporters
por: Zhang, Shun, et al.
Publicado: (2021) -
Design and Antiproliferative Evaluation of Novel Sulfanilamide Derivatives as Potential Tubulin Polymerization Inhibitors
por: Fu, Dong-Jun, et al.
Publicado: (2017) -
Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues
por: Khandan, Mojtaba, et al.
Publicado: (2018) -
The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
por: Mu, Yan, et al.
Publicado: (2015) -
Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)